Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support, Protocol Development, Implementation and Assays.
Abstract
This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.
Key facts
- NIH application ID
- 10083147
- Project number
- 272201300018I-P00002-759301900132-1
- Recipient
- EMORY UNIVERSITY
- Principal Investigator
- Mark Joseph Mulligan
- Activity code
- N01
- Funding institute
- NIH
- Fiscal year
- 2020
- Award amount
- $190,742
- Award type
- —
- Project period
- 2019-07-12 → 2020-12-31